Inactive Instrument

Highlights ProText Mobility, Inc. Other OTC

Equities

Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	02/22/02	CI
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	29/21/29	CI
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19/19/19	CI
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	19/18/19	CI
Protext Mobility, Inc. to Conduct Human Clinical Trial with Its Product Phytofare Catechin Complex	04/17/04	CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.	27/17/27	CI
Protext Mobility, Inc. Engages in the Development of Pharmaceutical Applications for the Highly Bioavailable Phytofare®	07/17/07	CI
Plandai SA completed the acquisition of ProText Mobility, Inc. in a reverse merger transaction.	31/16/31	CI
Plandai SA agreed to acquire ProText Mobility, Inc. in a reverse merger transaction.	23/16/23	CI

No results for this search